Etomethazene

Etomethazene
Identifiers
	IUPAC name 2-[(4-ethoxyphenyl)methyl]-N,N-diethyl-5-methyl-1H-benzimidazole-1-ethanamine;
JSmol)	Interactive image;
	SMILES CCOc3ccc(Cc2nc1cc(C)ccc1n2CCN(CC)CC)cc3;
	InChI InChI=1S/C23H31N3O/c1-5-25(6-2)14-15-26-22-13-8-18(4)16-21(22)24-23(26)17-19-9-11-20(12-10-19)27-7-3/h8-13,16H,5-7,14-15,17H2,1-4H3; Key:ZARKNPABJGEAOQ-UHFFFAOYSA-N;

Etomethazene (5-methyldesnitroetonitazene, 5-methyl etodesnitazene, Eto) is a benzimidazole derivative with opioid effects which has been sold as a designer drug over the internet since early 2022. It is an analogue of etonitazene where the nitro (NO₂) group has been replaced by a methyl (CH₃) group. While formal studies into its pharmacology have yet to be carried out, it showed far less potency than etonitazene itself. Etomethazene has an analgesic potency around 20 times that of morphine with a relatively short duration of about 120 min.^[1]^[2]^[3]

References

^ "Early signal alert: Emergence of online mentions of etomethazene". National Drug Early Warning System. 1 July 2022.
^ "5-methyl Etodesnitazene (citrate)". Caymanchem.com.
^ KLASSIFICERINGSDOKUMENT Narkotika. Etometazen (5-metyletodesnitazen)

This analgesic-related article is a stub. You can help Wikipedia by expanding it.

[1] "Early signal alert: Emergence of online mentions of etomethazene". National Drug Early Warning System. 1 July 2022.

[2] "5-methyl Etodesnitazene (citrate)". Caymanchem.com.

[3] KLASSIFICERINGSDOKUMENT Narkotika. Etometazen (5-metyletodesnitazen)

[1]

[2]

[3]

See also

References